Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Changes in Stockholders' Equity (Deficit)

v3.6.0.2
Consolidated Statement of Changes in Stockholders' Equity (Deficit) - USD ($)
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Beginning Balance at Dec. 31, 2013 $ (1,559,545) $ 24,565 $ 64,933,145 $ (66,517,255)
Beginning Balance, Shares at Dec. 31, 2013   24,565,447    
Stock-based compensation 6,280,629 $ 381 6,280,248  
Stock-based compensation, Shares   379,901    
Proceeds from the sale of common stock, net of offering costs 15,435,305 $ 2,380 15,432,925
Proceeds from the sale of common stock, net of offering costs, Shares   2,379,433    
Proceeds from the sale of common stock and warrants, net of offering costs      
Issuance of common stock from exercise of options 275,153 $ 310 274,843
Issuance of common stock from exercise of options, Shares   310,400    
Issuance of common stock from exercise of warrants 159,994 $ 2,336 157,658
Issuance of common stock from exercise of warrants, Shares   2,336,658    
Direct costs incurred before shares are issued (30,000) (30,000)
Transfer of warrant derivatives from liability to equity classification 2,203,443 2,203,443
Net loss (24,687,509) (24,687,509)
Ending Balance at Dec. 31, 2014 (1,922,530) $ 29,972 89,252,262 (91,204,764)
Ending Balance, Shares at Dec. 31, 2014   29,971,839    
Stock-based compensation 7,061,622 $ 345 7,061,277  
Stock-based compensation, Shares   344,784    
Proceeds from the sale of common stock, net of offering costs      
Proceeds from the sale of common stock and warrants, net of offering costs 37,637,959 $ 11,994 37,625,965
Proceeds from the sale of common stock and warrants, net of offering costs, Shares   11,993,641    
Issuance of common stock from exercise of options 15,680 $ 20 15,660
Issuance of common stock from exercise of options, Shares   20,000    
Issuance of common stock from exercise of warrants 157,940 $ 1,736 156,204
Issuance of common stock from exercise of warrants, Shares   1,736,277    
Direct costs incurred before shares are issued      
Transfer of warrant derivatives from liability to equity classification 48,691 48,691
Net loss (21,025,314)   (21,025,314)
Ending Balance at Dec. 31, 2015 21,974,048 $ 44,067 134,160,059 (112,230,078)
Ending Balance, Shares at Dec. 31, 2015   44,066,541    
Stock-based compensation 4,297,778 $ 82 4,297,696  
Stock-based compensation, Shares   81,700    
Proceeds from the sale of common stock, net of offering costs      
Proceeds from the sale of common stock and warrants, net of offering costs 16,022,667 $ 11,504 16,011,163
Proceeds from the sale of common stock and warrants, net of offering costs, Shares   11,504,427    
Issuance of common stock from exercise of options 18,105 $ 23 18,082
Issuance of common stock from exercise of options, Shares   23,212    
Issuance of common stock from exercise of warrants $ 126 (126)
Issuance of common stock from exercise of warrants, Shares   125,862    
Direct costs incurred before shares are issued  
Transfer of warrant derivatives from liability to equity classification 17,455 17,455
Net loss (24,321,724) (24,321,724)
Ending Balance at Dec. 31, 2016 $ 18,008,329 $ 55,802 $ 154,504,329 $ (136,551,802)
Ending Balance, Shares at Dec. 31, 2016   55,801,742